Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The use of the finasteride-adjusted Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator in a Mexican referral population: a validation study.

Urologia internationalis - 1 Jan 2012

Liang Yuanyuan, Ketchum Norma S, Louden Christopher, Jimenez-Rios Miguel A, Thompson Ian M, Camarena-Reynoso Hector R

Abstract excerpt

OBJECTIVES: To perform the first validation study of the finasteride-adjusted Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator (finPCPTRC) in a contemporary referral population in Mexico. METHODS: 837 patients referred to the Instituto Nacional de Cancerología, Mexico City, Mexico, between 2005 and 2009 were used to validate the finPCPTRC by examining various measures of discrimination and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Hormonal
Share to Chi-Square Distribution

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mass Screening

Share to Mexico

Share to Neoplasm Grading

Share to Proportional Hazards Models

Share to Prostate-Specific Antigen

Share to Referral and Consultation

Source

Identifiers

PMID: 22626812
DOI: 10.1159/000338270

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The use of the finasteride-adjusted Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator in a Mexican referral population: a validation study.PMID 22626812Read ↗

The US Preventive Services Task Force 2017 Draft Recommendation Statement on Screening for Prostate Cancer: An Invitation to Review and Comment.Semantic proximity Read ↗

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial.Semantic proximity Read ↗

Impact of a new diagnostic pathway for prostate cancer - From systematic transrectal to targeted MRI fusion transperineal biopsiesSemantic proximity Read ↗

A bibliometric analysis of use of Machine learning and Artificial intelligence in Prostate Cancer DetectionSemantic proximity Read ↗

What is the current status of metastatic prostate cancer in Colombia? A retrospective study based on publicly available state databasesSemantic proximity Read ↗

Diagnostic Performance of Prostate Cancer Disease-Specific Phenotypes Identified Using Real-World Databases: A Systematic Review.Semantic proximity Read ↗

Report prepared for the Health Technology Assessment panel of the NHS Executive on the diagnosis, management, treatment and costs of prostate cancer in England and Wales.Semantic proximity Read ↗

A review of targeted screening for prostate cancer: introducing the IMPACT study.Semantic proximity Read ↗

Implementation and first results of the Czech nationwide prostate cancer screening pilot programmeSemantic proximity Read ↗

Artificial neural networks for prostate carcinoma risk assessment: An overview.Semantic proximity Read ↗

Knowledge, Attitudes, and Practices Pertaining to Prostate Cancer Among Middle-Aged and Older Men: A Cross-Sectional Study in Zibo, ChinaSemantic proximity Read ↗

PSA density in the diagnosis of prostate cancer in the Chinese populationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.